Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3406 AL 3420

Combination therapy for Alzheimer's disease and related dementias

Bednar MM.

Prog Mol Biol Transl Sci. 2019;168:289-296. doi: 10.1016/bs.pmbts.2019.10.001. Epub 2019 Oct 24.

Carotenoids as Novel Therapeutic Molecules Against Neurodegenerative Disorders: Chemistry and Molecular Docking Analysis

Lakey-Beitia J, Kumar D J, Hegde ML, Rao KS.

Int J Mol Sci. 2019 Nov 7;20(22):5553. doi: 10.3390/ijms20225553.

Editorial: Multi Target - Directed Ligands in the Treatment of Alzheimer's Disease

Soukup O, Korabecny J.

Curr Alzheimer Res. 2019;16(9):771. doi: 10.2174/156720501609191029115310.

Neural stem cell therapy for neurovascular injury in Alzheimer's disease

Boese AC, Hamblin MH, Lee JP.

Exp Neurol. 2020 Feb;324:113112. doi: 10.1016/j.expneurol.2019.113112. Epub 2019 Nov 12.

Validation Prognostic of the Baylor Profound Mental Status Examination

Salmerón S, Lozoya S, Plaza L, Soler-Moratalla I, Solís J, Abizanda P.

Dement Geriatr Cogn Disord. 2019;48(1-2):113-122. doi: 10.1159/000504168. Epub 2019 Nov 18.

Direct reprogramming of terminally differentiated cells into neurons: A novel and promising strategy for Alzheimer's disease treatment

Yavarpour-Bali H, Ghasemi-Kasman M, Shojaei A.

Prog Neuropsychopharmacol Biol Psychiatry. 2020 Mar 2;98:109820. doi: 10.1016/j.pnpbp.2019.109820. Epub 2019 Nov 16.

Facing the complexity of Alzheimer's disease

Dallemagne P, Rochais C.

Future Med Chem. 2020 Feb;12(3):175-177. doi: 10.4155/fmc-2019-0310. Epub 2019 Nov 21.

Anthocyanins Potentially Contribute to Defense against Alzheimer's Disease

Afzal M, Redha A, AlHasan R.

Molecules. 2019 Nov 22;24(23):4255. doi: 10.3390/molecules24234255.

The use of Huperzia species for the treatment of Alzheimer's disease

Kim Thu D, Vui DT, Ngoc Huyen NT, Duyen DK, Thanh Tung B.

J Basic Clin Physiol Pharmacol. 2019 Nov 28;31(3):/j/jbcpp.2020.31.issue-3/jbcpp-2019-0159/jbcpp-2019-0159.xml. doi: 10.1515/jbcpp-2019-0159.

Autophagy induction in the treatment of Alzheimer's disease

Schmukler E, Pinkas-Kramarski R.

Drug Dev Res. 2020 Apr;81(2):184-193. doi: 10.1002/ddr.21605. Epub 2019 Nov 29.

PPARα serves as a new receptor of aspirin for neuroprotection

Patel D, Roy A, Pahan K.

J Neurosci Res. 2020 Apr;98(4):626-631. doi: 10.1002/jnr.24561. Epub 2019 Dec 3.

[Alzheimer's disease therapy: challenges and perspectives.]

Orlov MA.

Adv Gerontol. 2019;32(4):639-651.

Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease

Jia L, Piña-Crespo J, Li Y.

Mol Brain. 2019 Dec 4;12(1):104. doi: 10.1186/s13041-019-0525-5.

[Alzheimer's disease and singing: an application in mediated therapy]

Hamm S, Sudres JL, Menouer L, Brandibas G.

Soins Gerontol. 2019 Nov-Dec;24(140):15-19. doi: 10.1016/j.sger.2019.09.004.

[Mobile applications in alzheimer's disease. A systematic review of the literature]

Sánchez-Gutiérrez C, Ortega-Bastidas P, Cano-de-la-Cuerda R.

Rehabilitacion (Madr). 2019 Oct-Dec;53(4):247-275. doi: 10.1016/j.rh.2019.07.002. Epub 2019 Nov 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias